Etelcalcetide use During Maintenance Hemodialysis and Incidence of Parathyroidectomy After Kidney Transplantation

Etelcalcetide use During Maintenance Hemodialysis and Incidence of Parathyroidectomy After Kidney Transplantation

Introduction: Etelcalcetide is an i.v. calcimimetic agent, effectively reducing parathyroid hormone levels in patients on maintenance hemodialysis (HD). The clinical impact of discontinuing etelcalcetide at the time of kidney transplantation is unknown. Methods: We retrospectively reviewed all patie...

Full description

Saved in:
Bibliographic Details
Main Authors: Philippe Delaey, Arnaud Devresse, Johann Morelle, Danai Faitatzidou, Miren Iriarte, Nada Kanaan, Antoine Buemi, Michel Mourad, Tom Darius, Eric Goffin, Michel Jadoul, Laura Labriola, Pierre-Yves Decleire, Marie Rommelaere, Miguel-Ange Guillen, Benoit Buysschaert, Bénédicte Vanderperren, Charles Cuvelier, Benoît Georges, Eugenia Papakrivopoulou, Claude Braun, Gaëlle Gillerot, Jean-Philippe Lengelé, François Reginster, Philippe Leroy, Ann-Karolien Vandooren, Philippe Madhoun
Format: Article
Language:English
Published: Elsevier 2024-07-01
Series:Kidney International Reports
Subjects:
chronic hemodialysis
etelcalcetide
hyperparathyroidism
kidney transplantation
mineral metabolism
parathyroidectomy
Online Access:http://www.sciencedirect.com/science/article/pii/S2468024924016243
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

http://www.sciencedirect.com/science/article/pii/S2468024924016243

Similar Items